Deadline: June 03, 2014

Davina Rosen Marano


The Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School and the Food and Drug Law Institute are pleased to announce an upcoming collaborative academic symposium:


Emerging Issues and New Frontiers for FDA Regulation

Monday, October 20, 2014 


We are currently seeking abstracts for academic presentations/papers on the following topics:  

  • Stem cell therapies

  • Nanotechnologies

  • Genetic (and biomarker) tests

  • Gene therapies

  • Personalized medicine

  • Comparative efficacy research

  • Drug resistant pathogens

  • Globalized markets

  • Tobacco

  • GMO

  • Bioterrorism countermeasures

  • Mobile health technologies

  • Health IT

  • Drug shortages

  • Other related topics

Abstracts should be no longer than 1 page, and should be emailed to Davina Rosen Marano at by June 3, 2014. Questions should also be directed to Davina Rosen Marano.

We will notify selected participants by the end of June.  Selected participants will present at the symposium, and will be expected to submit a completed article by December 15, 2014 (after the event) to be considered for publication in a 2015 issue of FDLI’s Food and Drug Law Journal (FDLJ).  Publication decisions will be made based on usual FDLJ standards.

call for submissions fda food genetics international market pharmaceuticals regulation stem cells tobacco